DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rlgxmw/uveitis) has announced the addition of the "Uveitis - Pipeline Review, H2 2013" report to their offering.
'Uveitis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Uveitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Uveitis.
- A snapshot of the global therapeutic scenario for Uveitis.
- A review of the Uveitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Uveitis pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Uveitis.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Devise corrective measures for pipeline projects by understanding Uveitis pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Inovio Biomedical Corporation
Santen Pharmaceutical Co., Ltd.
Apitope International NV
Isotechnika Pharma Inc.
Enzo Biochem, Inc.
Can-Fite BioPharma Ltd.
Regeneron Pharmaceuticals, Inc.
Hanall Pharmaceutical Co., Ltd.
Artielle ImmunoTherapeutics, Inc.
ProtAffin Biotechnologie AG
and many more...
For more information visit http://www.researchandmarkets.com/research/rlgxmw/uveitis
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.